FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2794321815> ?p ?o ?g. }

• W2794321815 endingPage "S242" @default.
• W2794321815 startingPage "S232" @default.
• W2794321815 abstract "Typhoid fever remains a major public health problem globally. While new Vi conjugate vaccines hold promise for averting disease, the optimal programmatic delivery remains unclear. We aimed to identify the strategies and associated epidemiologic conditions under which Vi conjugate vaccines would be cost-effective.We developed a dynamic, age-structured transmission and cost-effectiveness model that simulated multiple vaccination strategies with a typhoid Vi conjugate vaccine from a societal perspective. We simulated 10-year vaccination programs with (1) routine immunization of infants (aged <1 year) through the Expanded Program on Immunization (EPI) and (2) routine immunization of infants through the EPI plus a 1-time catch-up campaign in school-aged children (aged 5-14 years). In the base case analysis, we assumed a 0.5% case-fatality rate for all cases of clinically symptomatic typhoid fever and defined strategies as highly cost-effective by using the definition of a low-income country (defined as a country with a gross domestic product of $1045 per capita). We defined incidence as the true number of clinically symptomatic people in the population per year.Vi conjugate typhoid vaccines were highly cost-effective when administered by routine immunization activities through the EPI in settings with an annual incidence of >50 cases/100000 (95% uncertainty interval, 40-75 cases) and when administered through the EPI plus a catch-up campaign in settings with an annual incidence of >130 cases/100000 (95% uncertainty interval, 50-395 cases). The incidence threshold was sensitive to the typhoid-related case-fatality rate, carrier contribution to transmission, vaccine characteristics, and country-specific economic threshold for cost-effectiveness.Typhoid Vi conjugate vaccines would be highly cost-effective in low-income countries in settings of moderate typhoid incidence (50 cases/100000 annually). These results were sensitive to case-fatality rates, underscoring the need to consider factors contributing to typhoid mortality (eg, healthcare access and antimicrobial resistance) in the global vaccination strategy." @default.
• W2794321815 created "2018-03-29" @default.
• W2794321815 creator A5032636970 @default.
• W2794321815 creator A5035517653 @default.
• W2794321815 creator A5055188763 @default.
• W2794321815 creator A5071005898 @default.
• W2794321815 creator A5078871250 @default.
• W2794321815 creator A5085839891 @default.
• W2794321815 creator A5089664523 @default.
• W2794321815 date "2018-02-12" @default.
• W2794321815 modified "2023-10-18" @default.
• W2794321815 title "Comparison of Strategies and Incidence Thresholds for Vi Conjugate Vaccines Against Typhoid Fever: A Cost-effectiveness Modeling Study" @default.
• W2794321815 cites W1964049648 @default.
• W2794321815 cites W1965265760 @default.
• W2794321815 cites W1968186813 @default.
• W2794321815 cites W1969807949 @default.
• W2794321815 cites W1992791261 @default.
• W2794321815 cites W2003602243 @default.
• W2794321815 cites W2005801715 @default.
• W2794321815 cites W2024069661 @default.
• W2794321815 cites W2046117193 @default.
• W2794321815 cites W2049532298 @default.
• W2794321815 cites W2051967926 @default.
• W2794321815 cites W2054323288 @default.
• W2794321815 cites W2067180295 @default.
• W2794321815 cites W2098082628 @default.
• W2794321815 cites W2101758302 @default.
• W2794321815 cites W2102315900 @default.
• W2794321815 cites W2102898060 @default.
• W2794321815 cites W2105908052 @default.
• W2794321815 cites W2108272529 @default.
• W2794321815 cites W2114213575 @default.
• W2794321815 cites W2117139605 @default.
• W2794321815 cites W2136369541 @default.
• W2794321815 cites W2136787564 @default.
• W2794321815 cites W2139462981 @default.
• W2794321815 cites W2142999073 @default.
• W2794321815 cites W2149004255 @default.
• W2794321815 cites W2152246075 @default.
• W2794321815 cites W2153397625 @default.
• W2794321815 cites W2195372528 @default.
• W2794321815 cites W2267991565 @default.
• W2794321815 cites W2290845654 @default.
• W2794321815 cites W2340127586 @default.
• W2794321815 cites W2340183786 @default.
• W2794321815 cites W2419529528 @default.
• W2794321815 cites W2527824850 @default.
• W2794321815 cites W2538460240 @default.
• W2794321815 cites W2576413724 @default.
• W2794321815 cites W2616147260 @default.
• W2794321815 cites W2739522893 @default.
• W2794321815 cites W2915420506 @default.
• W2794321815 cites W4243637892 @default.
• W2794321815 cites W4250873783 @default.
• W2794321815 doi "https://doi.org/10.1093/infdis/jix598" @default.
• W2794321815 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6226717" @default.
• W2794321815 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29444257" @default.
• W2794321815 hasPublicationYear "2018" @default.
• W2794321815 type Work @default.
• W2794321815 sameAs 2794321815 @default.
• W2794321815 citedByCount "34" @default.
• W2794321815 countsByYear W27943218152018 @default.
• W2794321815 countsByYear W27943218152019 @default.
• W2794321815 countsByYear W27943218152020 @default.
• W2794321815 countsByYear W27943218152021 @default.
• W2794321815 countsByYear W27943218152022 @default.
• W2794321815 countsByYear W27943218152023 @default.
• W2794321815 crossrefType "journal-article" @default.
• W2794321815 hasAuthorship W2794321815A5032636970 @default.
• W2794321815 hasAuthorship W2794321815A5035517653 @default.
• W2794321815 hasAuthorship W2794321815A5055188763 @default.
• W2794321815 hasAuthorship W2794321815A5071005898 @default.
• W2794321815 hasAuthorship W2794321815A5078871250 @default.
• W2794321815 hasAuthorship W2794321815A5085839891 @default.
• W2794321815 hasAuthorship W2794321815A5089664523 @default.
• W2794321815 hasBestOaLocation W27943218151 @default.
• W2794321815 hasConcept C120665830 @default.
• W2794321815 hasConcept C121332964 @default.
• W2794321815 hasConcept C127598652 @default.
• W2794321815 hasConcept C144024400 @default.
• W2794321815 hasConcept C147483822 @default.
• W2794321815 hasConcept C149923435 @default.
• W2794321815 hasConcept C159047783 @default.
• W2794321815 hasConcept C187212893 @default.
• W2794321815 hasConcept C187316915 @default.
• W2794321815 hasConcept C203014093 @default.
• W2794321815 hasConcept C22070199 @default.
• W2794321815 hasConcept C2779583294 @default.
• W2794321815 hasConcept C2780801004 @default.
• W2794321815 hasConcept C2908647359 @default.
• W2794321815 hasConcept C520601542 @default.
• W2794321815 hasConcept C61511704 @default.
• W2794321815 hasConcept C71924100 @default.
• W2794321815 hasConcept C99454951 @default.
• W2794321815 hasConceptScore W2794321815C120665830 @default.
• W2794321815 hasConceptScore W2794321815C121332964 @default.
• W2794321815 hasConceptScore W2794321815C127598652 @default.
• W2794321815 hasConceptScore W2794321815C144024400 @default.

• next